The role of Chinese medicine treatment for refractory liver disease

In the past decade, modern medicine has made significant progress in the treatment of refractory liver diseases, especially chronic hepatitis B and chronic hepatitis C. The use of a large number of nucleoside analogs has resulted in a significant slowdown in the incidence of hepatitis B. The application of a large number of nucleoside analogs has slowed down the incidence of hepatitis B considerably. However, these treatments are faced with two major dilemmas: 1) most of them require long-term medication; 2) many patients develop drug resistance sooner or later, and even a small percentage of patients still develop cirrhosis or hepatocellular carcinoma. Some of our hepatologists emphasize too much on antiviral and neglect the importance of body immunity in the treatment of this disease. In fact, numerous therapeutic effects show that only complete immune control is the satisfactory realm for the current treatment of chronic viral hepatitis. It is in this regard that traditional medicine of the motherland has a unique advantage. Each person’s immune status varies greatly. Individualized treatment through evidence-based therapy enables patients with liver disease to achieve optimal immune function, and to achieve the therapeutic goal together with or separately from Western medicine. However, in recent years, some doctors have taken advantage of the people’s eagerness for treatment to exaggerate the efficacy of traditional Chinese medicine, and the charlatans have even come up with some health care products to fool the patients. This is the reputation of Chinese medicine treatment is corrupted. Just as we buy things but also comparison shopping, see a doctor we often put their lives to the doctor, we should not only look at the text or the official publicity of a doctor, but more seriously examine the character of the doctor, to find a Chinese medicine practitioner suitable for their own.